The HemOnc Pulse Live at ASH 2022: Elias Jabbour, MD, on Immunotherapy Advances in ALL
By Chadi Nabhan, MD, MBA, FACP, Elias Jabbour, MD - Last Updated: December 13, 2022Elias Jabbour, MD, chats with The HemOnc Pulse host Chadi Nabhan, MD, MBA, FACP, about advances in frontline treatment for acute lymphoblastic leukemia (ALL), immunotherapy, using minimal residual disease data to tailor therapy, strategies for treating patients with relapsed disease, and more, during the 2022 American Society of Hematology Annual Meeting.
Post Tags:ASH22
Advertisement
Related Posts
After a follow-up of 24 months, the two-year relapse free survival was 54% and the two-year overall survival rate was 60%.
The effect of elevated BMI was more pronounced in older adolescent and young adults (AYAs) compared to younger AYAs.
Dr. Tasian discusses the path that took her to the best job in the world, silver linings along the way, and more.
The strategy is “potentially translatable to all T-cell derived hematological malignancies," according to researchers.
The pooled ORR was 97% and the pooled complete remission rate was 93% in patients with ALL.
Advertisement
Advertisement
Editorial Board
Sagar Lonial, MD, FACPEditor-in-Chief | Chief Medical Officer of Winship Cancer Institute at Emory University School of Medicine
Guillermo Garcia-Manero, MDAssociate Editor | Chief, Section of Myelodysplastic Syndromes, The University of Texas MD Anderson Cancer Center
Elias Jabbour, MDAssociate Editor | DB Lane Cancer Research Fund Distinguished Professor in Leukemia Research, MD Anderson Cancer Center
Kami Maddocks, MDAssociate Editor | Professor of Clinical Internal Medicine in the Division of Hematology at The Ohio State University
Thomas Martin, MDAssociate Editor | Clinical Research Director, UCSF Helen Diller Family Comprehensive Cancer Center
Jerald Radich, MDAssociate Editor | Professor in the Clinical Research Division and Kurt Enslein Endowed Chair at Fred Hutch
Laurie Sehn, MD, MPHAssociate Editor | Clinical Professor of Medical Oncology, British Columbia Cancer Centre for Lymphoid Cancer
630 Madison Ave.
Manalapan, NJ 07726
© 2023 Mashup Media, LLC. All rights reserved.